Abstract
MicroRNAs are structural components of an epigenetic mechanism of post-transcriptional regulation of messenger RNA translation. Recently, there is significant interest in the application of microRNA as a blood-based biomarker of underlying physiologic conditions, and the therapeutic administration of microRNA inhibitors and mimics. The purpose of this review is to describe the current body of knowledge on microRNA regulation of genes involved in lipid metabolism, and to introduce the role of microRNA in development and progression of atherosclerosis.
Original language | English (US) |
---|---|
Pages (from-to) | 12-20 |
Number of pages | 9 |
Journal | Metabolism: Clinical and Experimental |
Volume | 62 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2013 |
Keywords
- Dyslipidemia
- MicroRNA
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology